Target intelligence / Profile preview

Immune cells via paracrine factors and cell-cell contact

Molecular classification
Cellular process, Intercellular signaling
01

Overview

The phrase Immune cells via paracrine factors and cell-cell contact refers to a complex biological process of immunomodulation rather than a discrete molecular target. This process involves the regulation of immune cell activity through two primary modalities: the secretion of soluble mediators like cytokines and prostaglandins (paracrine signaling) and direct physical engagement of surface receptors (cell-cell contact or juxtacrine signaling). These mechanisms are fundamental to the function of regulatory T cells and mesenchymal stem cells in maintaining immune homeostasis and preventing autoimmunity (Nature Reviews Immunology, 2008). In therapeutic contexts, this terminology is frequently used to describe the pleiotropic effects of cell-based therapies, such as MSCs, which do not rely on a single lock-and-key drug-target interaction but instead engage multiple pathways simultaneously (Frontiers in Immunology, 2018). Because it encompasses a vast array of molecules—including IL-10, TGF-beta, and PD-L1—it is classified as a biological mechanism or a description of cellular behavior rather than a specific, druggable protein or receptor. Consequently, it does not fit the standard definition of a therapeutic target in a molecular sense.

Other names
Immunomodulation via paracrine and juxtacrine signalingCellular immune regulationParacrine and cell-contact mediated immunosuppression
02

Mechanism of action

This entry describes a broad physiological mechanism of action involving multiple molecular pathways and cell types rather than a single drug-target interaction.

03

Biological functions

Immune responseParacrine signalingCell-cell communicationImmunomodulationSignal transduction
04

Disease associations

InflammationAutoimmune diseaseCancerGraft-versus-host disease
05

Safety considerations

Systemic immunosuppressionCytokine release syndromeUnintended modulation of the tumor microenvironment
06

Biomarkers

Interleukin-10 (IL-10)Transforming growth factor beta (TGF-beta)Programmed death-ligand 1 (PD-L1)Indoleamine 2,3-dioxygenase (IDO)

Beyond the preview

Go deeper on Immune cells via paracrine factors and cell-cell contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cells via paracrine factors and cell-cell contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call